Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus

Lupus

Volumn 23, Issue 14, 2014, Pages 1517-1522

  Jung, J Y ^a   Koh, B R ^a   Bae, C B ^a   Kim, H A ^a   Suh, C H ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

atherosclerosis; carotid artery; disease activity; Systemic lupus erythematosus; vitamin D

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; AZATHIOPRINE; BIOLOGICAL MARKER; CALCITRIOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; VITAMIN D; CALCIFEDIOL;

ADULT; ANTICOAGULANT THERAPY; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY DISEASE; KOREAN (PEOPLE); LABORATORY TEST; MAJOR CLINICAL STUDY; MIDDLE AGED; RISK FACTOR; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGE; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; ECHOGRAPHY; INTIMA; SEVERITY OF ILLNESS INDEX;

ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CALCIFEDIOL; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA;

EID: 84911034110     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314544185     Document Type: Article

References (17)

1. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 2399-2406
2. Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010 ; 55: 1600-1607
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
4. Mcgreevy C, William D. New insight about vitamin D and cardiovascular disease. Ann Intern Med. 2011 ; 155: 820-826
5. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, et al. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus. 2012 ; 21: 477-484
6. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 51-60
7. Sutton-Tyrrell K, Wolfson SK, Thompson T, Kelsey SF. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke. 1992 ; 23: 215-220
8. Ruiz-Irastorza G, Egurbided MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford). 2008 ; 47: 920-923
9. Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int. 2011 ; 31: 1189-1194
10. Colombo BM, Murdaca G, Caiti M, et al. Intima-media thickness: A marker of accelerated atherosclerosis in women with systemic lupus erythematosus. Ann N Y Acad Sci. 2007 ; 1108: 121-126
11. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2003 ; 62: 1071-1077
12. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, et al. Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 151-159
13. Wu PW, Rhew EY, Dyer AR, et al. 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1387-1395
14. Rua-Figueroa I, Arencibia-Mireles O, Elvira M, et al. Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: A 2-year longitudinal study. Ann Rheum Dis. 2010 ; 69: 1136-1139
15. Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus. 2012 ; 21: 36-42
16. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157
17. Reynolds JA, Haque S, Berry JL, et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012 ; 51: 544-551